Europe Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1322 | Pages: 132 | May 2017 | Region: Europe


The Europe Infectious Disease Therapeutics Market was worth $ 23.45 Billion in 2016 and estimated to reach $ 32.86 Billion by the end of 2021 with a growing potential of 6.98 %.

Infectious diseases are caused by pathogens such as bacteria, viruses, parasites, fungi. These diseases will spread, directly or indirectly from one person to another person. So, anti-infective drugs are used to prevent the growth of such diseases. These drugs directly targets the causative agent and hinders the growth of the disease. Infectious diseases such as malaria, HIV, tuberculosis, influenza, salmonella pose a major challenge for public.

Some of the major factor that are driving the Europe infectious disease Market are increasing occurrence of infectious diseases, increasing health care expenditure and increasing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the factors that are hindering the growth of the market.

Based on Treatment, the market is segmented into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on target organism the market is segment into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is segmented into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the Europe Infectious disease therapeutics market is analyzed under various regions namely U.K, Germany, France, Italy and Spain

Some of the key players influencing the Europe Infectious disease Therapeutics Market F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, Astellas Pharma, AstraZeneca, Auritec Pharmaceuticals, Bayer, Bristol-Myers Squibb, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Sanofi.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Mode of Treatment                

                                5.1.1 Introduction           

                                5.1.2 Drugs        

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Topical

                                                5.1.2.3 Injections

                                                5.1.2.4 Others

                                5.1.3 Vaccines  

                                5.1.4 Y-o-Y Growth Analysis, By Mode of treatment         

                                5.1.5 Market Attractiveness Analysis, By Mode of treatment        

                                5.1.6 Market Share Analysis, By Mode of treatment         

                5.2 Target Organism                      

                                5.2.1 Introduction           

                                5.2.2 Antibacterial          

                                5.2.3 Antifungal

                                5.2.4 Antiviral   

                                5.2.5 Antiparasite           

                                5.2.6 others       

                                5.2.7 Y-o-Y Growth Analysis, By Target Organism               

                                5.2.8 Market Attractiveness Analysis, By Target Organism             

                                5.2.9 Market Share Analysis, By Target Organism              

                5.3 Infection type                           

                                5.3.1 Introduction           

                                5.3.2 Bacterial   

                                5.3.3 Viral           

                                5.3.4 Fungal       

                                5.3.5 parasitic   

                                5.3.6 others       

                                5.3.7 Y-o-Y Growth Analysis, By Infection type    

                                5.3.8 Market Attractiveness Analysis, By Infection type  

                                5.3.9 Market Share Analysis, By Infection Type   

                5.4 Distribution Channels                            

                                5.4.1 Hospitals  

                                5.4.2 Clinics        

                                5.4.3 Others      

                                5.4.4 Y-o-Y Growth Analysis, By Distribution Channels     

                                5.4.5 Market Attractiveness Analysis, By Distribution Channels   

                                5.4.6 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Mode of Treatment

                                                6.1.3.3 By Target organism

                                                6.1.3.4 By Infection Type

                                                6.1.3.5 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Mode of Treatment

                                                6.1.4.3 By Target organism

                                                6.1.4.4 By Infection Type

                                                6.1.4.5 By Distribution Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Mode of Treatment

                                                6.1.5.3 By Target organism

                                                6.1.5.4 By Infection Type

                                                6.1.5.5 By Distribution Channels

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Gilead Sciences                         

                8.3 GlaxoSmithKline                      

                8.4 Johnson & Johnson                 

                8.5 Merck & Co                

                8.6 Pfizer                            

                8.7 Achillion Pharmaceuticals                    

                8.8 Novartis                       

                8.9 Abbvie                         

                8.10 Astellas Pharma                     

                8.11 AstraZeneca                            

                8.12 Auritec Pharmaceuticals                     

                8.13 Bayer                          

                8.14 Bristol-Myers Squibb                           

                8.15 Chimerix Pharmaceuticals                 

                8.16 Cubist                         

                8.17 Eli Lilly                        

                8.18 Isis Pharmaceuticals                             

                8.19 pSivida                       

                8.20 Sanofi                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  2. Europe Drugs Market By Region, From 2016-2021 ( USD Billion )
  3. Europe vaccines Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  5. Europe Antibacterial Market By Region, From 2016-2021 ( USD Billion )
  6. Europe Antifungal Market By Region, From 2016-2021 ( USD Billion )
  7. Europe Antiviral Market By Region, From 2016-2021 ( USD Billion )
  8. Europe Antiparasite Market By Region, From 2016-2021 ( USD Billion )
  9. Europe Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  10. Europe Bacterial Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Viral Market By Region, From 2016-2021 ( USD Billion )
  12. Europe Fungal Market By Region, From 2016-2021 ( USD Billion )
  13. Europe Parasitic Market By Region, From 2016-2021 ( USD Billion )
  14. Europe Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  15. Europe Hospitals Market By Region, From 2016-2021 ( USD Billion )
  16. Europe Clinics Market By Region, From 2016-2021 ( USD Billion )
  17. U.K. Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  18. U.K. Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  19. U.K. Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  20. U.K. Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  21. Germany Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  22. Germany Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  23. Germany Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  24. Germany Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  25. France Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  26. France Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  27. France Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  28. France Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  29. Italy Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  30. Italy Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  31. Italy Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  32. Italy Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  33. Spain Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  34. Spain Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  35. Spain Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  36. Spain Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  37. Europe Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  38. Europe Oral Administration Market By Region, From 2016-2021 ( USD Billion )
  39. Europe Topical Market By Region, From 2016-2021 ( USD Billion )
  40. Europe Injections Market By Region, From 2016-2021 ( USD Billion )
  41. U.K. Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  42. Germany Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  43. France Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  44. Italy Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  45. Spain Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.